You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,576,070


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,576,070 protect, and when does it expire?

Patent 10,576,070 protects NYMALIZE and is included in one NDA.

Summary for Patent: 10,576,070
Title:Non-aqueous liquid nimodipine compositions
Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.
Inventor(s): Thomas; Hugh Greg (Carrollton, GA)
Assignee: Arbor Pharmaceuticals, LLC (Atlanta, GA)
Application Number:16/407,980
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,576,070

Introduction

When analyzing a patent, particularly one like United States Patent 10,576,070, it is crucial to delve into the specifics of its scope and claims. This patent, part of the Nymalize® Patents, is associated with non-aqueous liquid nimodipine compositions and is held by Arbor Pharmaceuticals, LLC. Here’s a detailed analysis of its scope, claims, and the broader patent landscape.

Patent Overview

United States Patent 10,576,070, titled "Non-Aqueous Liquid Nimodipine Compositions," was issued on March 3, 2020, from the United States Patent Application No. 16/407,980. This patent is one of several related to the Nymalize® Product, a formulation and dispenser system for nimodipine, a medication used to treat subarachnoid hemorrhage[2].

Claim Scope

The claim scope of a patent is critical as it defines the boundaries of the invention and the protection it offers. For Patent 10,576,070, the claims must be carefully crafted to ensure they are neither too broad nor too narrow.

Importance of Claim Scope

A common misconception is that broader claims are always better. However, broader claims are more difficult to get granted and easier to invalidate. The claim scope must be anchored to the embodiments disclosed in the specification to avoid invalidation grounds such as the abstract idea exception or failure to meet the written description requirement[5].

Claim Analysis

The claims in Patent 10,576,070 would typically include:

  • Independent Claims: These define the broadest scope of the invention and are crucial for determining the patent's overall protection.
  • Dependent Claims: These narrow down the scope by adding additional limitations to the independent claims.
  • Claim Language: The language used in the claims must be precise and clear to avoid ambiguity and potential invalidation.

For example, if the independent claim is too broad, it may invoke generic processes rather than a specific means or method, which could lead to it being classified as an abstract idea and thus unpatentable[5].

Patent Claims and Scope Metrics

Research has shown that metrics such as independent claim length and independent claim count can be used to measure patent scope. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process. The examination process often narrows the scope of patent claims, making them more specific and less prone to invalidation[3].

Patent Examination Process

The examination process for Patent 10,576,070 would have involved a thorough review by the USPTO to ensure that the claims are valid and not overly broad. This process includes:

  • Prior Art Search: Ensuring that the invention is novel and non-obvious over existing prior art.
  • Claim Amendments: Potentially narrowing down the claims to overcome objections raised during the examination.
  • Office Actions: Responding to office actions from the USPTO to address any issues with the patent application[1].

Patent Landscape

The patent landscape for non-aqueous liquid nimodipine compositions is complex, with multiple patents and applications related to similar inventions. Here are some key points:

Related Patents

  • Patent Family: Patent 10,576,070 is part of a family of patents related to the Nymalize® Product, including other patents such as 7,070,581, 8,517,997, and 10,342,787. These patents collectively protect various aspects of the formulation and dispenser system[2].
  • International Patents: To ensure global protection, similar patents may have been filed in other countries through international patent offices such as the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO)[1].

Litigation and Enforcement

Patents like 10,576,070 are often involved in litigation to protect against infringement. For instance, the holders of the Nymalize® Patents have taken legal action against Amneal Pharmaceuticals, LLC, for submitting an Abbreviated New Drug Application (ANDA) for a generic version of the Nymalize® Product[2].

Tools and Resources for Patent Search

To understand the scope and claims of a patent like 10,576,070, several tools and resources are available:

  • Patent Public Search: A web-based tool provided by the USPTO that offers enhanced access to prior art and patent documentation[1].
  • Global Dossier: A service that provides access to the file histories of related applications from participating IP Offices, helping to identify office actions and related applications[1].
  • Patent and Trademark Resource Centers (PTRCs): Local resources that offer training in patent search techniques and access to local search resources[1].

Key Takeaways

  • Claim Scope Precision: The scope of the claims in Patent 10,576,070 must be carefully balanced to ensure they are neither too broad nor too narrow.
  • Examination Process: The patent examination process plays a crucial role in narrowing down the claims to ensure validity.
  • Patent Landscape: Understanding the broader patent landscape, including related patents and international filings, is essential for comprehensive protection.
  • Litigation: Patents are often involved in litigation to protect against infringement, highlighting the importance of robust claims.

FAQs

Q: What is the significance of claim scope in a patent application? A: The claim scope defines the boundaries of the invention and the protection it offers. It must be balanced to avoid being too broad or too narrow to ensure validity and enforceability.

Q: How does the patent examination process affect the claims of a patent? A: The examination process often narrows down the claims to overcome objections, ensuring that the claims are valid and not overly broad.

Q: What tools are available for searching and analyzing patents? A: Tools such as the Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) are available for searching and analyzing patents.

Q: Why is it important to understand the patent landscape for a specific invention? A: Understanding the patent landscape helps in identifying related patents, potential infringement issues, and the need for international protection.

Q: How can overly broad claims affect the validity of a patent? A: Overly broad claims can lead to invalidation due to grounds such as the abstract idea exception or failure to meet the written description requirement.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Arnold B. Calmann Katherine A. Escanlar - One Gateway Center: https://insight.rpxcorp.com/litigation_documents/14723168
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. U.S. Department of Commerce - U.S. Patent and Trademark Office: https://www.commerce.gov/bureaus-and-offices/uspto
  5. Rimon Law - The Importance of Getting the Claim Scope Right in a US Patent Application: https://www.rimonlaw.com/the-importance-of-getting-the-claim-scope-right-in-a-us-patent-application-i/

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,576,070

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Azurity NYMALIZE nimodipine SOLUTION;ORAL 203340-002 Apr 8, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y A METHOD FOR THE IMPROVEMENT OF NEUROLOGICAL OUTCOME BY REDUCING THE INCIDENCE AND SEVERITY OF ISCHEMIC DEFICITS IN ADULT PATIENTS WITH SUBARACHNOID HEMORRHAGE (SAH) FROM RUPTURED INTRACRANIAL BERRY ANEURYSMS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.